Diurnal stability and long-term repeatability of neurometabolites using single voxel 1H magnetic resonance spectroscopy

被引:7
作者
Al-iedani, Oun [1 ,2 ]
Arm, Jameen [2 ]
Ribbons, Karen [3 ]
Lea, Rodney [2 ]
Lechner-Scott, Jeannette [2 ,3 ,4 ]
Ramadan, Saadallah [1 ,2 ]
机构
[1] Univ Newcastle, Fac Hlth & Med, Sch Hlth Sci, Callaghan, NSW 2308, Australia
[2] Hunter Med Res Inst, Kookaburra Circuit, New Lambton Hts, NSW 2305, Australia
[3] John Hunter Hosp, Dept Neurol, Lookout Rd, New Lambton Hts, NSW 2305, Australia
[4] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia
关键词
Diurnal; Test-retest; Long-term repeatability; 1H-MRS; PCG metabolites; PROTON MR SPECTROSCOPY; IN-VIVO; HUMAN BRAIN; 3; T; METABOLITE CONCENTRATIONS; QUANTIFICATION PRECISION; ANTERIOR CINGULATE; H-1; SPECTROSCOPY; SHORT-ECHO; REPRODUCIBILITY;
D O I
10.1016/j.ejrad.2018.09.020
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: This study was designed to evaluate the diurnal stability and long-term repeatability and reliability of one-dimensional (1D) hydrogen magnetic resonance spectroscopy (1H-MRS) in vitro and in vivo at 3 T. Material and method: A standard brain phantom was used for in vitro study. In vivo diurnal evaluation involved ten healthy subjects, while repeatability study involved six subjects. MRS was acquired from posterior cingulate gyrus (PCG), and processed with LCModel. Diurnal effects were assessed with repeated measures ANOVAs, repeatability was evaluated using coefficient of variation (CV), while reliability was assessed with standard error measurement (SEM) and intra-class correlation coefficient (ICC). Results: Diurnal metabolic changes in vitro were non-significant. The intra/inter-in vitro CVs for the major metabolites; N-acetylaspartate (NAA), creatine (Cr), myo-inositol (mI), glutamate+ glutamine (Glx) and total choline (tCho) were 1-3%/2-6%, respectively. Statistically significant in vivo diurnal effects were only seen for glycerophosphocholine (GPC, + 10%, F= 10.6, p = 0.001) and Glx (+6%, F = 5.1, p = 0.018). The intra/inter-subject CVs for the major metabolites ranged from 2-5%/5-9%, respectively. The major metabolites displayed ICC ranging from 0.5-0.7 and low SEM (0.001-0.078) reflecting high reliability in detecting neurometabolites. The inter-week interval for in vivo measurements had minimal effect on metabolite ratios (F = 1.4, p = 0.09). Conclusion: In vitro MRS showed no diurnal effects and minimal variation in metabolite levels. Most PCG metabolites are not altered diurnally. The low in vivo variability of metabolite concentration supports the use of localised MRS on clinical 3 T scanners for reliable neurometabolic profiling of the brain.
引用
收藏
页码:107 / 113
页数:7
相关论文
共 40 条
  • [1] Single-voxel 1H spectroscopy in the human hippocampus at 3 T using the LASER sequence: characterization of neurochemical profile and reproducibility
    Allaili, Najib
    Valabregue, Romain
    Auerbach, Edward J.
    Guillemot, Vincent
    Yahia-Cherif, Lydia
    Bardinet, Eric
    Jabourian, Maritza
    Fossati, Philippe
    Lehericy, Stephane
    Marjanska, Malgorzata
    [J]. NMR IN BIOMEDICINE, 2015, 28 (10) : 1209 - 1217
  • [2] Allen P., 2014, SPSS statistics version 22: A practical guide
  • [3] Regional apparent metabolite concentrations in young adult brain measured by 1H MR spectroscopy at 3 tesla
    Baker, Eva H.
    Basso, Gianpaolo
    Barker, Peter B.
    Smith, Mari A.
    Bonekamp, David
    Horska, Alena
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2008, 27 (03) : 489 - 499
  • [4] Bartha R, 2000, MAGNET RESON MED, V44, P185, DOI 10.1002/1522-2594(200008)44:2<185::AID-MRM4>3.0.CO
  • [5] 2-V
  • [6] Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: Magnetic resonance spectroscopy and immunologic correlation
    Bladowska, Joanna
    Zimny, Anna
    Koltowska, Anna
    Szewczyk, Pawel
    Knysz, Brygida
    Gasiorowski, Jacek
    Furdal, Michal
    Sasiadek, Marek J.
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2013, 82 (04) : 686 - 692
  • [7] Brooks WM, 1999, MAGNET RESON MED, V41, P193, DOI 10.1002/(SICI)1522-2594(199901)41:1<193::AID-MRM27>3.0.CO
  • [8] 2-P
  • [9] Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic Imaging
    Chard, DT
    McLean, MA
    Parker, GJM
    MacManus, DG
    Miller, DH
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 15 (02) : 219 - 225
  • [10] Choi Y., 2016, ECTRIMS ONLINE LIB, V16